BG103703A - Метод за получаване на кисели соли на тровафлоксацин - Google Patents

Метод за получаване на кисели соли на тровафлоксацин Download PDF

Info

Publication number
BG103703A
BG103703A BG103703A BG10370399A BG103703A BG 103703 A BG103703 A BG 103703A BG 103703 A BG103703 A BG 103703A BG 10370399 A BG10370399 A BG 10370399A BG 103703 A BG103703 A BG 103703A
Authority
BG
Bulgaria
Prior art keywords
acid
formula
compound
trovafloxacin
mineral
Prior art date
Application number
BG103703A
Other languages
Bulgarian (bg)
English (en)
Inventor
Timothy Norris
Peter R. Rose
Keith Michael
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of BG103703A publication Critical patent/BG103703A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
BG103703A 1998-09-03 1999-09-01 Метод за получаване на кисели соли на тровафлоксацин BG103703A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
BG103703A true BG103703A (bg) 2001-08-31

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103703A BG103703A (bg) 1998-09-03 1999-09-01 Метод за получаване на кисели соли на тровафлоксацин

Country Status (40)

Country Link
US (1) US6359137B1 (ko)
EP (1) EP0989119A1 (ko)
JP (1) JP3354526B2 (ko)
KR (1) KR20000022858A (ko)
CN (1) CN1248580A (ko)
AP (1) AP1118A (ko)
AR (1) AR021475A1 (ko)
AU (1) AU761035B2 (ko)
BG (1) BG103703A (ko)
BR (1) BR9904082A (ko)
CA (1) CA2281244C (ko)
CO (1) CO5251466A1 (ko)
EA (1) EA002340B1 (ko)
EE (1) EE04118B1 (ko)
GE (1) GEP20022785B (ko)
GT (1) GT199900142A (ko)
HN (1) HN1999000141A (ko)
HR (1) HRP990274A2 (ko)
HU (1) HUP9902967A3 (ko)
ID (1) ID23718A (ko)
IL (1) IL131614A0 (ko)
IN (1) IN191583B (ko)
IS (1) IS5168A (ko)
MA (1) MA24966A1 (ko)
MY (1) MY130800A (ko)
NO (1) NO994261L (ko)
NZ (1) NZ337605A (ko)
OA (1) OA11152A (ko)
PA (1) PA8481001A1 (ko)
PE (1) PE20001026A1 (ko)
PL (1) PL335246A1 (ko)
SG (1) SG74748A1 (ko)
SK (1) SK116599A3 (ko)
SV (1) SV1999000144A (ko)
TN (1) TNSN99164A1 (ko)
TR (1) TR199902138A2 (ko)
TW (1) TW520369B (ko)
UY (1) UY25686A1 (ko)
YU (1) YU43199A (ko)
ZA (1) ZA995630B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
RU2147303C1 (ru) * 1994-01-18 2000-04-10 Пфайзер Инк. Промежуточные продукты и способ получения солей нафтиридонкарбоновой кислоты
EP0789697B1 (en) * 1995-06-06 1998-06-17 Pfizer Inc. CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JP3188476B2 (ja) * 1995-08-29 2001-07-16 ファイザー・インコーポレーテッド 両性イオン形トロバフロキサシン
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas

Also Published As

Publication number Publication date
EA199900708A2 (ru) 2000-04-24
SK116599A3 (en) 2000-05-16
HRP990274A2 (en) 2000-10-31
NO994261L (no) 2000-03-06
AR021475A1 (es) 2002-07-24
UY25686A1 (es) 2000-03-31
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
JP2000086658A (ja) 2000-03-28
US6359137B1 (en) 2002-03-19
IL131614A0 (en) 2001-01-28
IS5168A (is) 2000-03-04
PE20001026A1 (es) 2000-10-11
MY130800A (en) 2007-07-31
HUP9902967A3 (en) 2000-11-28
AP1118A (en) 2002-11-21
TR199902138A2 (xx) 2000-04-21
CO5251466A1 (es) 2003-02-28
TNSN99164A1 (fr) 2005-11-10
JP3354526B2 (ja) 2002-12-09
AP9901667A0 (en) 1999-12-31
PL335246A1 (en) 2000-03-13
MA24966A1 (fr) 2000-04-01
YU43199A (sh) 2002-11-15
ID23718A (id) 2000-05-11
GEP20022785B (en) 2002-09-25
NO994261D0 (no) 1999-09-02
EA199900708A3 (ru) 2000-08-28
GT199900142A (es) 2001-02-15
SV1999000144A (es) 2000-09-05
AU4482699A (en) 2000-03-16
CA2281244C (en) 2003-05-20
EP0989119A1 (en) 2000-03-29
TW520369B (en) 2003-02-11
EE04118B1 (et) 2003-08-15
EE9900457A (et) 2000-04-17
EA002340B1 (ru) 2002-04-25
CA2281244A1 (en) 2000-03-03
ZA995630B (en) 2001-03-01
PA8481001A1 (es) 2000-09-29
HU9902967D0 (en) 1999-10-28
SG74748A1 (en) 2000-08-22
HUP9902967A2 (hu) 2000-05-28
CN1248580A (zh) 2000-03-29
AU761035B2 (en) 2003-05-29
IN191583B (ko) 2003-12-06
BR9904082A (pt) 2000-09-12
NZ337605A (en) 2001-03-30
HN1999000141A (es) 2000-06-19

Similar Documents

Publication Publication Date Title
US6184380B1 (en) Process for preparing naphthyridones and intermediates
US6198000B1 (en) Intermediates useful in the synthesis of quinoline antibiotics
CA3121631A1 (en) Substituted heterocycle fused gamma-carbolines synthesis
US6114531A (en) Process for preparing quinolone and naphthyridone carboxylic acids
RU2147303C1 (ru) Промежуточные продукты и способ получения солей нафтиридонкарбоновой кислоты
BG103703A (bg) Метод за получаване на кисели соли на тровафлоксацин
WO1988001270A1 (en) Pyridopyrimidinediones
US4482714A (en) Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives
MXPA99008100A (en) Procedure for preparing aci additional trovafloxacin salts
US4515949A (en) [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals
US6057455A (en) Preparation of intermediates useful in the synthesis of quinoline antibiotics
SK3899A3 (en) Process for the preparation of naphthyridones and intermediates
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US20020095043A1 (en) Process for preparing naphthyridones and intermediates
CZ312199A3 (cs) Způsob přípravy trovafloxacinových kyselinových solí
CA2209688A1 (en) Preparation of intermediates useful in the synthesis of quinoline antibiotics
MXPA99007034A (en) Procedure for preparing acids quinolone and naftiridone carboxili
CZ11999A3 (cs) Způsob výroby naftyridonů a meziprodukty
JPH11255744A (ja) 2,4−二置換および2,3,5−三置換ピロール誘導体およびその製造中間体
CZ9902648A3 (cs) Způsob výroby chinolon- a naftyridonkarboxylových kyselin